NXTC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

NextCure  Inc

NASDAQ | NXTC

11.15

USD

$0.00

(

0.00%

)

At Close (As of Dec 12, 2025)

$38.59M

Market Cap

-

P/E Ratio

-23.81

EPS

$15.74

52 Week High

$2.68

52 Week Low

HEALTHCARE

Sector

NXTC Chart

Recent Chart
Price Action

NXTC Technicals

Tags:

NXTC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2.9M
Total Revenue $0
Cost Of Revenue $2.9M
Costof Goods And Services Sold $2.9M
Operating Income -$60M
Selling General And Administrative $16M
Research And Development $41M
Operating Expenses $60M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.9M
Income Before Tax -$56M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$56M
Comprehensive Income Net Of Tax -
Ebit -$57M
Ebitda -$54M
Net Income -$56M

Revenue & Profitability

Earnings Performance

NXTC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $81M
Total Current Assets $72M
Cash And Cash Equivalents At Carrying Value $28M
Cash And Short Term Investments $28M
Inventory -
Current Net Receivables $300K
Total Non Current Assets $9.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $41M
Other Current Assets $2.9M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $9.6M
Current Accounts Payable $5.4M
Deferred Revenue -
Current Debt -
Short Term Debt $796K
Total Non Current Liabilities $5.8M
Capital Lease Obligations $5.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $5.9M
Other Current Liabilities $3.4M
Other Non Current Liabilities $661K
Total Shareholder Equity $65M
Treasury Stock -
Retained Earnings -$380M
Common Stock $28K
Common Stock Shares Outstanding $2.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$41M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.9M
Capital Expenditures $474K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $55M
Cashflow From Financing $144K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$56M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2.9M
Total Revenue $0
Cost Of Revenue $2.9M
Costof Goods And Services Sold $2.9M
Operating Income -$60M
Selling General And Administrative $16M
Research And Development $41M
Operating Expenses $60M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.9M
Income Before Tax -$56M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$56M
Comprehensive Income Net Of Tax -
Ebit -$57M
Ebitda -$54M
Net Income -$56M

NXTC News

NXTC Profile

NextCure  Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

NextCure, Inc. (NXTC) is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, focused on developing groundbreaking immunomedicines for cancer and immune-related disorders. Leveraging its proprietary NEX-T technology platform, NextCure aims to restore and enhance immune function to create novel treatment options that address critical unmet medical needs. With an extensive pipeline and a strategic commitment to tackling pressing healthcare challenges, NextCure is well-positioned to become a significant player in the rapidly evolving immunotherapy market.

LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
NVDA
-2.13%
$177.07
CGC
+41.58%
$1.59
OCG
+116.24%
$1.97
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.44%
$0.13
PLUG
+1.69%
$2.40
TSLA
+0.84%
$450.67
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
ADAP
-15.14%
$0.05
FRMI
-32.81%
$10.24
ASST
-2.40%
$0.89
ZDGE
+30.45%
$3.17
AKAN
+19.31%
$0.93
TLRY
+29.53%
$10.92
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
APLT
-44.12%
$0.12
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
PLTD
+2.69%
$6.49
ASBP
-7.84%
$0.09
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
IRBT
-12.80%
$4.36
PLTR
-2.75%
$182.37
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
MARA
-3.37%
$11.44
CRWV
-8.46%
$79.97
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
IVP
-6.59%
$0.04
RZLT
+11.07%
$1.55
AAL
+0.70%
$15.06
TWOH
0.00%
$0.00
AMD
-3.86%
$212.88
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
RKLB
-1.22%
$62.75
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
SOUN
-0.46%
$11.97
AMZN
-1.66%
$226.45
GOOGL
-1.09%
$309.01
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
SNAP
-1.17%
$7.55
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
MU
-4.71%
$246.27
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
CRCG
-13.05%
$2.93
ORCL
-3.57%
$191.74
GPUS
-4.61%
$0.27
ASTS
-7.92%
$78.03
EOSE
-8.85%
$14.98
SPR
+0.22%
$39.50
HPE
-1.91%
$24.06
LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
NVDA
-2.13%
$177.07
CGC
+41.58%
$1.59
OCG
+116.24%
$1.97
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.44%
$0.13
PLUG
+1.69%
$2.40
TSLA
+0.84%
$450.67
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
ADAP
-15.14%
$0.05
FRMI
-32.81%
$10.24
ASST
-2.40%
$0.89
ZDGE
+30.45%
$3.17
AKAN
+19.31%
$0.93
TLRY
+29.53%
$10.92
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
APLT
-44.12%
$0.12
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
PLTD
+2.69%
$6.49
ASBP
-7.84%
$0.09
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
IRBT
-12.80%
$4.36
PLTR
-2.75%
$182.37
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
MARA
-3.37%
$11.44
CRWV
-8.46%
$79.97
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
IVP
-6.59%
$0.04
RZLT
+11.07%
$1.55
AAL
+0.70%
$15.06
TWOH
0.00%
$0.00
AMD
-3.86%
$212.88
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
RKLB
-1.22%
$62.75
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
SOUN
-0.46%
$11.97
AMZN
-1.66%
$226.45
GOOGL
-1.09%
$309.01
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
SNAP
-1.17%
$7.55
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
MU
-4.71%
$246.27
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
CRCG
-13.05%
$2.93
ORCL
-3.57%
$191.74
GPUS
-4.61%
$0.27
ASTS
-7.92%
$78.03
EOSE
-8.85%
$14.98
SPR
+0.22%
$39.50
HPE
-1.91%
$24.06
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.